On the 29th, Donga Pharmaceutical announced the launch of four new "Care Treat" products under its pet healthcare brand "Vetple" at Emart Mollis Pet stores nationwide.


Donga Pharmaceutical Launches Four Types of Pet Dog Supplements 'Vetple Care Treat' at Emart Molly’s Pet. Donga Pharmaceutical

Donga Pharmaceutical Launches Four Types of Pet Dog Supplements 'Vetple Care Treat' at Emart Molly’s Pet. Donga Pharmaceutical

View original image

The Care Treat lineup addresses common health concerns in dogs, consisting of four types: joint, eye, respiratory, and overall health. Donga Pharmaceutical’s veterinary experts participated in the product development. Pet owners can select the appropriate product based on their dog's health needs.


The main ingredients for each product have been differentiated according to the specific health concern. The Joint Care Treat contains N-acetylglucosamine (NAG), boswellia, and green-lipped mussel. The Eye Care Treat features Seven Berry concentrate powder, marigold, and astaxanthin. The Respiratory Care Treat combines Saururus chinensis, bromelain, and balloon flower root. The Comprehensive Care Treat includes a multivitamin complex, colostrum, and taurine.


All products utilize "ImmunoHeal," Donga Pharmaceutical’s patented ingredient for canine immune health. Donga Pharmaceutical explained that these supplements are produced 100% domestically and adopt a "4 FREE" formula, meaning they contain no artificial coloring, flavoring, sweeteners, or by-products. To enhance palatability, the treats are made in a chicken-based jerky type and are individually packaged per serving.



A representative from Donga Pharmaceutical commented, “Vetple Care Treat was designed to help pet owners address their dogs’ health with greater expertise, ease, and taste,” adding, “We will continue to introduce a wide range of products so that pets and owners can enjoy healthy daily lives together.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing